Gabapentin Lawsuit

Studies show taking gabapentin (Neurontin®) for off-label uses can significantly increase the risk of dementia and cognitive impairment in patients. If you or a loved one was harmed, you may be eligible for compensation from a gabapentin lawsuit.

​​At Simmons Hanly Conroy, we’re dedicated to fighting for families affected by dangerous medications. Call (855) 264-6270 now to see if you may qualify for a gabapentin dementia lawsuit.

Get a Free Consultation

What’s Going on with Neurontin & Gabapentin Lawsuits?

Used as an anti-seizure medication, Gabapentin is also frequently prescribed for off-label uses, including neck and back pain, hot flashes, and mood disorders like anxiety. However, researchers have raised concerns that broader use may increase the risk of cognitive decline.

One study found that patients with chronic low back pain who received 6 or more gabapentin prescriptions had a 29% increased risk of dementia and an 85% increased risk of mild cognitive impairment within a 10-year period.

Those who’ve been harmed may be able to file a Gabapentin lawsuit against the manufacturer for failing to warn about the potential danger.

Gabapentin Lawsuits at a Glance

  • Gabapentin is manufactured by Pfizer and sold under the brand name Neurontin.
  • The medication is intended to treat epileptic seizures and nerve pain caused by shingles.
  • Even though off-label use is common, Pfizer has yet to warn of neurological effects linked to the medication.

At Simmons Hanly Conroy, we have over 25 years of experience standing up to powerful corporations that put consumers in harm’s way. Get a free case review to see if we can help you seek justice from a Pfizer Neurontin lawsuit​.

The Risk of Dementia from Gabapentin

While Gabapentin is approved by the U.S. Food and Drug Administration (FDA) for shingles-related nerve pain and epileptic seizures, it’s frequently prescribed for other conditions it wasn’t designed to treat. New research has shown that off-label use of gabapentin may have health consequences.

Repeated gabapentin use is linked to higher rates of dementia and mild cognitive impairment over time, as reported by Regional Anesthesia & Pain Medicine. The medication affects how nerve signals are transmitted in the brain, which may affect memory and other cognitive functions, especially with repeated use.

The study also found that the elevated risk was not limited to older adults. Individuals between the ages of 35 and 49 had more than twice the risk of dementia and more than three times the risk of mild cognitive impairment compared to those who did not take gabapentin.

Use of the drug has increased significantly in recent years, meaning many patients may be at risk of long-term neurological effects.

The Risk of Dementia from Gabapentin background image
Who Is Eligible for the Gabapentin Lawsuit? background image

Who Is Eligible for the Gabapentin Lawsuit?

Gabapentin lawsuit eligibility revolves around someone taking the drug and suffering an injury that wasn’t listed on the warning label.

You may be eligible for a gabapentin lawsuit if you or a loved one:

  • Used gabapentin 6 or more times between 2000 and 2024
  • Was prescribed gabapentin for a health condition other than seizures or nerve pain
  • Received a diagnosis of early-onset dementia before age 65

State laws known as statutes of limitations limit how much time you have to take legal action. For that reason, it’s important to reach out to our team as soon as possible after a diagnosis.

Our Gabapentin Lawyers Can Help Families Nationwide

At Simmons Hanly Conroy, our gabapentin lawsuit lawyers can help families in all 50 states seek compensation for dementia linked to the medication.

We have over 25 years of experience standing up to powerful companies like Pfizer and evening the playing field for those harmed, including by dangerous medications.

Our team has recovered over $11.7 billion total for clients nationwide.

There are no upfront costs or hourly fees to work with our gabapentin lawsuit​ attorneys. We only get paid if we secure compensation for you.

Call (855) 264-6270 now or fill out our contact form to get started with a free legal consultation.

Our Gabapentin Lawyers Can Help Families Nationwide background image

Neurontin Pfizer Lawsuit FAQs

Can gabapentin cause dementia?

When gabapentin is used to treat certain off-label health conditions, researchers have found an increased risk of dementia and cognitive impairment.

One study found that patients who received 6 or more prescriptions of gabapentin for low back pain were 89% more likely to develop mild cognitive impairment and 29% more likely to develop dementia.

Find out if you can file a gabapentin lawsuit for dementia. Get a free legal consultation now.

Is there a class action lawsuit for gabapentin?

At this time, there isn’t a gabapentin class action lawsuit for dementia. Instead, gabapentin lawsuits are being filed on an individual basis by families nationwide.

This allows each case to be evaluated based on an individual’s specific diagnosis, degree of cognitive decline, and other factors that may affect potential gabapentin settlement​ and verdict amounts.

How much do gabapentin attorneys charge?

At Simons Hanly Conroy, there are no upfront costs or hourly fees to work with our lawyers for a gabapentin lawsuit​. We work on a contingency-fee basis, which means you pay nothing unless we secure compensation for you.

Call (855) 264-6270 now to see if our gabapentin lawyers can fight for your family.

Simmons Support TeamLast modified:
Legal Reviewer Laurence Valere NassifReviewed by:Laurence Valere Nassif

Managing Partner

  • Fact-Checked
  • Legal Reviewer

With over 15 years of legal experience, Larry has secured millions of dollars on behalf of his clients and tried several cases to verdict. In 2007, he was a member of the trial team that achieved a $47.5 million verdict in Humeston v. Merck & Co. on behalf of patients who suffered cardiovascular injuries as a result of taking Vioxx. In 2003, he also helped secure a $2 million verdict on behalf of his client who suffered from Rezulin-related liver damage. He has also helped families impacted by mesothelioma and other asbestos-related diseases from around the country.

View Sources
  1. BMJ Group. “Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks.” Retrieved from: https://bmjgroup.com/nerve-pain-drug-gabapentin-linked-to-increased-dementia-cognitive-impairment-risks/.
  2. Harvard Health Publishing. “Gabapentin: Uses, side effects, and what you should know if you’ve been prescribed this medication.” Retrieved from: https://www.health.harvard.edu/healthy-aging-and-longevity/gabapentin-uses-side-effects-and-what-you-should-know-if-youve-been-prescribed-this-medication.
  3. Psychiatry Online. “Studies Raise Concerns About Gabapentin and Cognitive Risk.” Retrieved from: https://psychiatryonline.org/doi/10.1176/appi.pn.2026.02.2.10.
  4. U.S. Food and Drug Administration. “NEURONTIN (gabapentin): HIGHLIGHTS OF PRESCRIBING INFORMATION.” Retrieved from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf.